tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Holding DRMA?
Track your performance easily

Dermata Therapeutics (DRMA) Technical Analysis

113 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Dermata Therapeutics is a Buy.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 1.26, while Dermata Therapeutics’s (DRMA) share price is $1.15, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 1.45, while Dermata Therapeutics’s (DRMA) share price is $1.15, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Nov 22, 2024, 09:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.62
0.85
1.00
1.23
1.38
1.61
1.76
Fibonacci
0.85
0.99
1.08
1.23
1.37
1.46
1.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Nov 22, 2024, 09:43 AM
Period
Simple
Exponential
MA5
1.12Buy
1.15Buy
MA10
1.20Sell
1.19Sell
MA20
1.27Sell
1.26Sell
MA50
1.44Sell
1.45Sell
MA100
1.74Sell
2.02Sell
MA200
3.39Sell
3.72Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 1.19, while Dermata Therapeutics’s (DRMA) share price is $1.15, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 2.02, while Dermata Therapeutics’s (DRMA) share price is $1.15, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $1.15 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 1.44, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $1.15 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 1.74, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $1.15 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 3.39, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Nov 22, 2024, 09:43 AM
Name
Value
Implied Action
RSI (14)
39.24
Neutral
STOCH (9,6)
17.88
Buy
STOCHRSI (14)
16.36
Buy
MACD (12,26)
-0.09
Buy
ADX (14)
12.61
Buy
Williams %R
-79.55
Buy
CCI (14)
-86.22
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
28.24
Sell
ROC
-5.74
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 39.24, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 12.61, creating a Buy signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -86.22, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -5.74, creating a Sell signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Sell.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 39.24, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.09, which suggests DRMA is a Buy.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 1.12, which suggests DRMA is a Buy.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 1.27, which suggests DRMA is a Sell.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 1.44, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 3.39, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -79.55, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is -86.22, which suggests DRMA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis